Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.845
-0.140 (-4.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $7.57 million as of April 28, 2026. Its market cap has increased by 440.56% in one year.
Market Cap
7.57M
Enterprise Value
2.18M
1-Year Change
440.56%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $7.57M, a decrease of -78.00%. That is a compound annual growth rate of -23.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.90M | 21.54% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 8.56M |
| Creative Medical Technology Holdings | 8.43M |
| PharmaCyte Biotech | 8.25M |
| MetaVia | 8.21M |
| Indaptus Therapeutics | 7.69M |
| TransCode Therapeutics | 7.61M |
| GridAI Technologies | 7.56M |
| BioAtla | 7.47M |